| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chf Clinical Develop Ofcr | EVP, Chf Clinical Develop Offc
1 company
Schneider Eugene is an EVP, Chf Clinical Develop Ofcr at IONIS PHARMACEUTICALS INC. Recent SEC Form 4 filings include 0 buys and 1 sell.
Estimated insider holdings value: $5.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 18, 2023 | IONS Ionis Pharmaceuticals Inc | EVP, Chf Clinical Develop Ofcr | Sale+OE | 4,752 | $39.57 | $188,051.85 | -17.5% | -8.6% | +27.2% |